INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 41h ago
HOUSE PTR1h ago
SEC 13F1h ago
ROBINHOOD CHAIN1h ago
Corporate insider
MK

McCulloch Kevin

See RemarksCIK 0002031695

EDGAR filingsOpen in network
Disclosed transactions15
Buys / sells0 / 5
Max Insider Score18
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
14
MK
McCulloch KevinSee Remarks
XERSXeris Biopharma Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$153K
15.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Xeris Biopharma Holdings, Inc.See Remarks · Jan 9, 2026
7
MK
McCulloch KevinSee Remarks
XERSXeris Biopharma Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL
$250K
25.0K sh
Sep 28, 2026
Sep 29, 2026
traded Sep 28, 2026
+1d
SEC FORM 4

Evidence

9
MK
McCulloch KevinSee Remarks
XERSXeris Biopharma Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$127K
15.0K sh
Sep 1, 2026Sep 1, 2026
traded Sep 1, 2026
+0dSEC FORM 4

Evidence

18
MK
McCulloch KevinSee Remarks
XERSXeris Biopharma Holdings, Inc.
Tax withholding
F$177K
21.9K sh
Aug 1, 2026Aug 21, 2026
traded Aug 1, 2026
+20dSEC FORM 4

Evidence

16
MK
McCulloch KevinSee Remarks
XERSXeris Biopharma Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$723K
90.0K sh
Jul 1, 2026Jul 2, 2026
traded Jul 1, 2026
+1dSEC FORM 4

Evidence

5
MK
McCulloch KevinSee Remarks
XERSXeris Biopharma Holdings, Inc.
Option exercise
M$15.76
4 sh
Mar 12, 2026Mar 16, 2026
traded Mar 12, 2026
+4dSEC FORM 4

Evidence

5
MK
McCulloch KevinSee Remarks
XERSXeris Biopharma Holdings, Inc.
Option exercise
M$15.76
4 sh
Mar 12, 2026Mar 16, 2026
traded Mar 12, 2026
+4dSEC FORM 4

Evidence

8
MK
McCulloch KevinSee Remarks
XERSXeris Biopharma Holdings, Inc.
Option exercise
M$200K
48.9K sh
Mar 12, 2026Mar 16, 2026
traded Mar 12, 2026
+4dSEC FORM 4

Evidence

8
MK
McCulloch KevinSee Remarks
XERSXeris Biopharma Holdings, Inc.
Option exercise
M$200K
48.9K sh
Mar 12, 2026Mar 16, 2026
traded Mar 12, 2026
+4dSEC FORM 4

Evidence

8
MK
McCulloch KevinSee Remarks
XERSXeris Biopharma Holdings, Inc.
Tax withholding
F$201K
27.3K sh
Jan 31, 2026Feb 2, 2026
traded Jan 31, 2026
+2dSEC FORM 4

Evidence

9
MK
McCulloch KevinSee Remarks
XERSXeris Biopharma Holdings, Inc.
Grant or award
A—
168.5K sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC FORM 4

Evidence

8
MK
McCulloch KevinSee Remarks
XERSXeris Biopharma Holdings, Inc.
Tax withholding
F$223K
30.3K sh
Jan 31, 2026Feb 2, 2026
traded Jan 31, 2026
+2dSEC FORM 4

Evidence

5
MK
McCulloch KevinSee Remarks
XERSXeris Biopharma Holdings, Inc.
Grant or award
A—
225.2K sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC FORM 4

Evidence

11
MK
McCulloch KevinSee Remarks
XERSXeris Biopharma Holdings, Inc.
Tax withholding
F$504K
68.5K sh
Jan 31, 2026Feb 2, 2026
traded Jan 31, 2026
+2dSEC FORM 4

Evidence

8
MK
McCulloch KevinSee Remarks
XERSXeris Biopharma Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$120K
15.0K sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC FORM 4

Evidence